Cre expressed under Pdgfrb promoter enabling conditional recombine expression in pericytes and smooth vascular muscle cells (tissue-specific loxP knockout/knockin)
| Inventor | Institute |
|---|---|
| Ralf H. Adams | Cancer Research UK, London Research Institute: Lincoln's Inn Fields |
| SKU: | 151534 |
|---|---|
| Product description: | Cre expressed under Pdgfrb promoter enabling conditional recombine expression in pericytes and smooth vascular muscle cells (tissue-specific loxP knockout/knockin) |
| Conditional: | Yes |
| Conditional description: | Pdgfrb-Cre enables conditional, pericyte and smooth vascular muscle cell knockout/knockin/transgene expression of loxP flanked genes. |
| Genetic background: | A Pdgfrb-Cre transgene vector, containing a genomic Pdgfrb promoter fragment fused to Cre recombinase and a polyA sequence, was injected into fertilised 129/C57BL6 oocytes. Founder lines were backcrossed to establish transgenic lines on a mixed 129/C57BL6 background. |
| Production details: | A Pdgfrb-Cre transgene vector, containing a genomic Pdgfrb promoter fragment fused to Cre recombinase and a polyA sequence, was injected into fertilised 129/C57BL6 oocytes. Founder lines were backcrossed to establish transgenic lines on a mixed 129/C57BL6 background. |
| Cat. #: | 151534 |
|---|---|
| Research Fields: | Cancer; Genetics; Immunology; Tissue-specific biology |
| Target: | Cre recombinase under Pdgfrb promoter |
| Disease: | Cancer |
| Model: | Conditional KO |
| Shipping conditions: | Embryo/Spermatoza- Dry Ice |
|---|
| References: |
Kogata et al. 2009. Genes Dev. 23(19):2278-83. PMID: 19797768. Integrin-linked kinase controls vascular wall formation by negatively regulating Rho/ROCK-mediated vascular smooth muscle cell contraction. Foo et al. 2006. Cell. 124(1):161-73. PMID: 16413489. Ephrin-B2 controls cell motility and adhesion during blood-vessel-wall assembly. |
|---|
Please note we may take up to three days to respond to your enquiry.
CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.